AnaptysBio, Inc. (ANAB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 515.50M |
| Enterprise Value | 142.41M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 29.61 |
| Price/Book (mrq) | 5.85 |
| Enterprise Value/Revenue | 8.30 |
| Enterprise Value/EBITDA | -0.99 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | -0.29 |
| 52-Week Change 3 | -9.37% |
| S&P500 52-Week Change 3 | 21.08% |
| 52 Week High 3 | 27.50 |
| 52 Week Low 3 | 13.36 |
| 50-Day Moving Average 3 | 22.96 |
| 200-Day Moving Average 3 | 20.06 |
Share Statistics
| Avg Vol (3 month) 3 | 327.33k |
| Avg Vol (10 day) 3 | 312.35k |
| Shares Outstanding 5 | 27.32M |
| Implied Shares Outstanding 6 | 26.76M |
| Float 8 | 14.73M |
| % Held by Insiders 1 | 0.39% |
| % Held by Institutions 1 | 111.18% |
| Shares Short (Apr 15, 2024) 4 | 4.27M |
| Short Ratio (Apr 15, 2024) 4 | 9.52 |
| Short % of Float (Apr 15, 2024) 4 | 23.38% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 15.95% |
| Shares Short (prior month Mar 15, 2024) 4 | 4.14M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -386.41% |
Management Effectiveness
| Return on Assets (ttm) | -18.47% |
| Return on Equity (ttm) | -93.44% |
Income Statement
| Revenue (ttm) | 17.16M |
| Revenue Per Share (ttm) | 0.64 |
| Quarterly Revenue Growth (yoy) | 32.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | -156.42M |
| Net Income Avi to Common (ttm) | -163.62M |
| Diluted EPS (ttm) | -6.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 390.9M |
| Total Cash Per Share (mrq) | 14.61 |
| Total Debt (mrq) | 328.62M |
| Total Debt/Equity (mrq) | 373.00% |
| Current Ratio (mrq) | 10.87 |
| Book Value Per Share (mrq) | 3.31 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -120.8M |
| Levered Free Cash Flow (ttm) | -73.42M |
© 2024 Yahoo. All rights reserved.